Clinically, GI problems usually appear in the first 2 to 6 weeks and often improve after 2 to 3 months if doses are increased gradually
[DOI] [PMC free article] [PubMed] [Google Scholar] 26
Their effects are more likely to counteract retatrutide heart rate increases because nifedipine (an L-type calcium channel blocker) was shown to partially reduce retatrutide cardiac effects in laboratory studies
adults say theyve taken a GLP-1 medication
Most people focus on the GLP-1 appetite suppression because it is the most noticeable early effect
Cardiovascular Outcomes This section reviews current evidence regarding GLP-1 RAs effects on MACE, PAD, CAD, HF, blood pressure, and AF, with detailed findings of trials and meta-analyses discussed in Tables 1 and 2 Major Adverse Cardiac Events Among Patients with T2DM Strong evidence supports using GLP-1 RAs to reduce MACE among patients with T2DM and established CVD